Del Labs Announces Management Changes, New OTC Products
This article was originally published in The Tan Sheet
Executive Summary
Del Labs former Chief Operating Officer Charles Hinkaty took the helm as president and CEO Aug. 19, succeeding retiring head William McMenemy
You may also be interested in...
Del Labs
Former President and CEO William McMenemy has departed the company to pursue other interests, and has not retired, as reported in the Aug. 22 issue of "The Tan Sheet." Del Labs announced last month the exec was stepping down as CEO, but will continue to serve on its board of directors. McMenemy was succeeded by Chief Operating Officer William Hinkaty (1"The Tan Sheet" Aug. 22, 2005, p. 11)...
Church & Dwight Brushes Off Orajel, Brushes Up Current Brand Support
Church & Dwight has backed out of an agreement that gave the firm an option to purchase Del Labs'Orajel line in order to concentrate resources on its existing oral care lines, the firm announced Dec. 7
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC